Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET EARLY CALL: Markets Buoyed By US Stimulus Progress

Mon, 08th Feb 2021 07:02

(Alliance News) - Stock prices in London are seen opening higher at the start of the week, with the mood in global markets lifted by hopes for a new US stimulus package.

US President Joe Biden seized on feeble US employment data, published on Friday, to argue the world's largest economy needs his USD1.9 trillion pandemic relief package, which cleared a key Senate hurdle without support from the Republican opposition.

"I believe the American people are looking right now to their government for help," Biden said after a meeting with top Democratic lawmakers. "So I'm going to act. I'm going to act fast."

IG futures indicate the FTSE 100 index is to open 40.2 points higher at 6,529.53 on Monday. The blue-chip index closed down 0.2%, or 14.39 points at 6,489.33 on Friday.

"At the back end of last week, the Biden administration put in motion a plan to get the USD1.9 trillion stimulus package signed off without support from Republican lawmakers. President Biden has a history of fostering good relations with politicians from across the aisle as well as seeking consensus on issues but this time he is determined to put the American people first," CMC Markets analyst David Madden said.

"The stimulus move also helped US equities notch up a record close. Janet Yellen, the US treasury secretary, claimed the US economy could return to full employment next year if President Biden's USD1.9 trillion relief package is passed. The positive sentiment from the US at the end of last week helped Asian equity markets. European stock markets are on track for a positive start."

On Friday, the Dow Jones Industrial Average closed up 0.3%, the S&P 500 up 0.4%, and the Nasdaq Composite up 0.6%.

The Japanese Nikkei 225 index jumped 2.2% on Monday, closing above the 29,000 mark. In China, the Shanghai Composite was 0.9% higher in late trade, while the Hang Seng index in Hong Kong is up 0.3%.

"Chinese has released anti-monopoly news today, aimed squarely at China big-tech companies. Markets seem to have priced this in for now though, with mainland markets slightly higher and large Hong Kong-listed China technology companies outperforming there this morning," OANDA Asia Pacific Senior Market Analyst Jeffrey Halley said.

Tencent Holdings shares were 1.0% higher in Hong Kong.

In Sydney, the ASX 200 closed up 0.6%.

Sterling was trading at USD1.3726 on Monday morning, largely flat from USD1.3728 at the London equities close on Friday.

CMC's Madden added: "The UK continues to be one of the best countries in the world as far as the vaccination rollout is concerned, approximately 17% of the population have received their first jab of the vaccine. It is not all good news on the health front though, the AstraZeneca-Oxford vaccine is not effective against the South African strain of the coronavirus."

South Africa has temporarily suspended the AstraZeneca and Oxford University jab against a new variant found in the country, according to the health department and top local scientists.

The AstraZeneca-Oxford vaccine protects against the original Covid-19 strain, but its efficacy drops off substantially when it comes to the new variant called B.1.351 or 501.V2, raising serious concerns, said Shabir Madhi, the professor of vaccinology at the University of the Witwatersrand, citing a new local study involving 2,000 participants.

The euro stood at USD1.2033 on Monday morning London time, up from USD1.2025 at the European equities close on Friday. Against the yen, the dollar was trading at JPY105.51, improved from JPY105.45 at the same time Friday.

Brent oil was quoted at USD59.76 a barrel, up from USD59.62 a barrel at the London equities close Friday. Gold fetched USD1,815.23 an ounce, up from USD1,808.40.

A quiet economic calendar on Monday has German industrial production figures at 0700 GMT.

The UK corporate calendar on Monday has full-year results from property manager Inland Homes and trading statements from industrial and electronic products distributor Electrocomponents and consumer goods brand designer UP Global Sourcing Holdings.

Later in the week, the US earnings season picks up pace again, with social networking site Twitter reporting on Tuesday, soft drinks heavyweight Coca-Cola on Wednesday, and Walt Disney on Thursday.

By Eric Cunha; ericcunha@alliancenews.com;

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.